0001708138-20-000026.txt : 20200403 0001708138-20-000026.hdr.sgml : 20200403 20200403160814 ACCESSION NUMBER: 0001708138-20-000026 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200401 FILED AS OF DATE: 20200403 DATE AS OF CHANGE: 20200403 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LAROSA JOSEPH J CENTRAL INDEX KEY: 0001238303 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 20773398 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2020-04-01 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001238303 LAROSA JOSEPH J 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 EVP General Counsel and Secret Common Stock 2020-04-01 4 M 0 5000 59.2 A 19438 D Common Stock 2020-04-01 4 F 0 2757 488.22 D 16681 D Common Stock 2020-04-01 4 M 0 5000 59.2 A 21681 D Common Stock 2020-04-01 4 F 0 2757 488.22 D 18924 D Common Stock 2020-04-01 4 M 0 5000 59.2 A 23924 D Common Stock 2020-04-01 4 F 0 2689 488.22 D 21235 D Common Stock 2020-04-02 4 S 0 192 484.58 D 21043 D Common Stock 2020-04-02 4 S 0 441 485.65 D 20602 D Common Stock 2020-04-02 4 S 0 485 486.61 D 20117 D Common Stock 2020-04-02 4 S 0 470 487.71 D 19647 D Common Stock 2020-04-02 4 S 0 1626 488.26 D 18021 D Common Stock 2020-04-02 4 S 0 734 489.72 D 17287 D Common Stock 2020-04-02 4 S 0 484 490.32 D 16803 D Common Stock 2020-04-02 4 S 0 450 491.42 D 16353 D Common Stock 2020-04-02 4 S 0 521 492.62 D 15832 D Common Stock 2020-04-02 4 S 0 652 493.35 D 15180 D Common Stock 2020-04-02 4 S 0 111 494.36 D 15069 D Common Stock 2020-04-02 4 S 0 321 495.19 D 14748 D Common Stock 2020-04-02 4 S 0 210 496.5 D 14538 D Common Stock 2020-04-02 4 S 0 100 497.32 D 14438 D Common Stock 255 I By 401(k) Plan Non-Qualified Stock Option (right to buy) 59.2 2020-04-01 4 M 0 5000 0.0 D 2021-09-01 Common Stock 5000 49933 D Non-Qualified Stock Option (right to buy) 59.2 2020-04-01 4 M 0 5000 0.0 D 2021-09-01 Common Stock 5000 44933 D Non-Qualified Stock Option (right to buy) 59.2 2020-04-01 4 M 0 5000 0.0 D 2021-09-01 Common Stock 5000 39933 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 192 shares of Company stock on April 2, 2020 at prices ranging from $484.12 to $484.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price. Represents volume-weighted average price of sales of 441 shares of Company stock on April 2, 2020 at prices ranging from $485.01 to $485.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price. Represents volume-weighted average price of sales of 485 shares of Company stock on April 2, 2020 at prices ranging from $486.15 to $486.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price. Represents volume-weighted average price of sales of 470 shares of Company stock on April 2, 2020 at prices ranging from $487.32 to $487.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price. Represents volume-weighted average price of sales of 1,626 shares of Company stock on April 2, 2020 at prices ranging from $488.00 to $488.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price. Represents volume-weighted average price of sales of 734 shares of Company stock on April 2, 2020 at prices ranging from $489.31 to $489.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price. Represents volume-weighted average price of sales of 484 shares of Company stock on April 2, 2020 at prices ranging from $490.11 to $490.80. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price. Represents volume-weighted average price of sales of 450 shares of Company stock on April 2, 2020 at prices ranging from $491.13 to $491.70. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price. Represents volume-weighted average price of sales of 521 shares of Company stock on April 2, 2020 at prices ranging from $492.22 to $492.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price. Represents volume-weighted average price of sales of 652 shares of Company stock on April 2, 2020 at prices ranging from $493.01 to $493.54. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price. Represents volume-weighted average price of sales of 111 shares of Company stock on April 2, 2020 at prices ranging from $494.29 to $494.38. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price. Represents volume-weighted average price of sales of 321 shares of Company stock on April 2, 2020 at prices ranging from $495.09 to $495.24. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price. Represents volume-weighted average price of sales of 210 shares of Company stock on April 2, 2020 at prices ranging from $496.37 to $496.64. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price. The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant. /s/**Joseph J. LaRosa 2020-04-03